The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Thyroid Hormone Therapy Market Research Report 2024
Synopsis
Thyroid hormone replacement therapy is the primary treatment for hypothyroidism, a condition characterized by an underactive thyroid gland. The goal of this therapy is to restore normal thyroid hormone levels in the body and alleviate symptoms. The most commonly prescribed medication for thyroid hormone replacement is levothyroxine sodium, a synthetic form of the hormone thyroxine (T4).
Global Thyroid Hormone Therapy market is projected to reach US$ 5456.4 million in 2029, increasing from US$ 4531 million in 2022, with the CAGR of 2.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Thyroid Hormone Therapy market research.
One of the key drivers of the thyroid hormone replacement therapy market is the increasing prevalence of hypothyroidism worldwide. Hypothyroidism is a common endocrine disorder, and its prevalence is rising due to factors such as aging populations, lifestyle changes, and improved detection and diagnosis. This growing prevalence of hypothyroidism is creating a larger patient pool requiring thyroid hormone replacement therapy, thereby driving the demand for related medications and treatments. Additionally, advancements in healthcare infrastructure, increased awareness about thyroid disorders, and expanding access to healthcare services in developing regions are further contributing to the growth of the thyroid hormone replacement therapy market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Thyroid Hormone Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbvie
Mylan Pharma
Merck
Pfizer
Lannett Company
Novartis
Fresenius Kabi
IBSA Institut Biochimique
Piramal Critical Care
Abbott
Segment by Type
Oral
Injection
Segment by Application
Hypothyroidism
Hyperthyroidism
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Thyroid Hormone Therapy report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Thyroid hormone replacement therapy is the primary treatment for hypothyroidism, a condition characterized by an underactive thyroid gland. The goal of this therapy is to restore normal thyroid hormone levels in the body and alleviate symptoms. The most commonly prescribed medication for thyroid hormone replacement is levothyroxine sodium, a synthetic form of the hormone thyroxine (T4).
Global Thyroid Hormone Therapy market is projected to reach US$ 5456.4 million in 2029, increasing from US$ 4531 million in 2022, with the CAGR of 2.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Thyroid Hormone Therapy market research.
One of the key drivers of the thyroid hormone replacement therapy market is the increasing prevalence of hypothyroidism worldwide. Hypothyroidism is a common endocrine disorder, and its prevalence is rising due to factors such as aging populations, lifestyle changes, and improved detection and diagnosis. This growing prevalence of hypothyroidism is creating a larger patient pool requiring thyroid hormone replacement therapy, thereby driving the demand for related medications and treatments. Additionally, advancements in healthcare infrastructure, increased awareness about thyroid disorders, and expanding access to healthcare services in developing regions are further contributing to the growth of the thyroid hormone replacement therapy market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Thyroid Hormone Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbvie
Mylan Pharma
Merck
Pfizer
Lannett Company
Novartis
Fresenius Kabi
IBSA Institut Biochimique
Piramal Critical Care
Abbott
Segment by Type
Oral
Injection
Segment by Application
Hypothyroidism
Hyperthyroidism
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Thyroid Hormone Therapy report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thyroid Hormone Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Thyroid Hormone Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hypothyroidism
1.3.3 Hyperthyroidism
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Thyroid Hormone Therapy Market Perspective (2018-2029)
2.2 Thyroid Hormone Therapy Growth Trends by Region
2.2.1 Global Thyroid Hormone Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Thyroid Hormone Therapy Historic Market Size by Region (2018-2023)
2.2.3 Thyroid Hormone Therapy Forecasted Market Size by Region (2024-2029)
2.3 Thyroid Hormone Therapy Market Dynamics
2.3.1 Thyroid Hormone Therapy Industry Trends
2.3.2 Thyroid Hormone Therapy Market Drivers
2.3.3 Thyroid Hormone Therapy Market Challenges
2.3.4 Thyroid Hormone Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thyroid Hormone Therapy Players by Revenue
3.1.1 Global Top Thyroid Hormone Therapy Players by Revenue (2018-2023)
3.1.2 Global Thyroid Hormone Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Thyroid Hormone Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Thyroid Hormone Therapy Revenue
3.4 Global Thyroid Hormone Therapy Market Concentration Ratio
3.4.1 Global Thyroid Hormone Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thyroid Hormone Therapy Revenue in 2022
3.5 Thyroid Hormone Therapy Key Players Head office and Area Served
3.6 Key Players Thyroid Hormone Therapy Product Solution and Service
3.7 Date of Enter into Thyroid Hormone Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Thyroid Hormone Therapy Breakdown Data by Type
4.1 Global Thyroid Hormone Therapy Historic Market Size by Type (2018-2023)
4.2 Global Thyroid Hormone Therapy Forecasted Market Size by Type (2024-2029)
5 Thyroid Hormone Therapy Breakdown Data by Application
5.1 Global Thyroid Hormone Therapy Historic Market Size by Application (2018-2023)
5.2 Global Thyroid Hormone Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Thyroid Hormone Therapy Market Size (2018-2029)
6.2 North America Thyroid Hormone Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Thyroid Hormone Therapy Market Size by Country (2018-2023)
6.4 North America Thyroid Hormone Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Thyroid Hormone Therapy Market Size (2018-2029)
7.2 Europe Thyroid Hormone Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Thyroid Hormone Therapy Market Size by Country (2018-2023)
7.4 Europe Thyroid Hormone Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Thyroid Hormone Therapy Market Size (2018-2029)
8.2 Asia-Pacific Thyroid Hormone Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Thyroid Hormone Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Thyroid Hormone Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Thyroid Hormone Therapy Market Size (2018-2029)
9.2 Latin America Thyroid Hormone Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Thyroid Hormone Therapy Market Size by Country (2018-2023)
9.4 Latin America Thyroid Hormone Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thyroid Hormone Therapy Market Size (2018-2029)
10.2 Middle East & Africa Thyroid Hormone Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Thyroid Hormone Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Thyroid Hormone Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Detail
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Thyroid Hormone Therapy Introduction
11.1.4 Abbvie Revenue in Thyroid Hormone Therapy Business (2018-2023)
11.1.5 Abbvie Recent Development
11.2 Mylan Pharma
11.2.1 Mylan Pharma Company Detail
11.2.2 Mylan Pharma Business Overview
11.2.3 Mylan Pharma Thyroid Hormone Therapy Introduction
11.2.4 Mylan Pharma Revenue in Thyroid Hormone Therapy Business (2018-2023)
11.2.5 Mylan Pharma Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Thyroid Hormone Therapy Introduction
11.3.4 Merck Revenue in Thyroid Hormone Therapy Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Thyroid Hormone Therapy Introduction
11.4.4 Pfizer Revenue in Thyroid Hormone Therapy Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Lannett Company
11.5.1 Lannett Company Company Detail
11.5.2 Lannett Company Business Overview
11.5.3 Lannett Company Thyroid Hormone Therapy Introduction
11.5.4 Lannett Company Revenue in Thyroid Hormone Therapy Business (2018-2023)
11.5.5 Lannett Company Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Thyroid Hormone Therapy Introduction
11.6.4 Novartis Revenue in Thyroid Hormone Therapy Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Detail
11.7.2 Fresenius Kabi Business Overview
11.7.3 Fresenius Kabi Thyroid Hormone Therapy Introduction
11.7.4 Fresenius Kabi Revenue in Thyroid Hormone Therapy Business (2018-2023)
11.7.5 Fresenius Kabi Recent Development
11.8 IBSA Institut Biochimique
11.8.1 IBSA Institut Biochimique Company Detail
11.8.2 IBSA Institut Biochimique Business Overview
11.8.3 IBSA Institut Biochimique Thyroid Hormone Therapy Introduction
11.8.4 IBSA Institut Biochimique Revenue in Thyroid Hormone Therapy Business (2018-2023)
11.8.5 IBSA Institut Biochimique Recent Development
11.9 Piramal Critical Care
11.9.1 Piramal Critical Care Company Detail
11.9.2 Piramal Critical Care Business Overview
11.9.3 Piramal Critical Care Thyroid Hormone Therapy Introduction
11.9.4 Piramal Critical Care Revenue in Thyroid Hormone Therapy Business (2018-2023)
11.9.5 Piramal Critical Care Recent Development
11.10 Abbott
11.10.1 Abbott Company Detail
11.10.2 Abbott Business Overview
11.10.3 Abbott Thyroid Hormone Therapy Introduction
11.10.4 Abbott Revenue in Thyroid Hormone Therapy Business (2018-2023)
11.10.5 Abbott Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
